Funding for this research was provided by:
Japanese Agency for Medical Research and Development (5fk0108046h0003)
Kurozumi Medical Foundation
Received: 14 July 2020
Accepted: 22 November 2020
First Online: 30 November 2020
Ethics approval and consent to participate
: This study was conducted with the approval from the ethical review committee of Department of Medical Research (Myanmar) (ERC number: 000816), IRB number (IRB00008835) and this work was supported by the research grants number “419” from the Institutional Review Board (IRB), University of Miyazaki for recombinant experiments.Written informed consents were obtained from all subjects who were 18 years or older. When the participants were under 18 years old, written informed consent from parents or guardians as well as written assent from participants were obtained.Information collected from each participant was kept confidential. Participation in this research was entirely voluntary and the participants had the right to withdraw from the research at any time.
: Not applicable.
: The authors declare that they have no competing interests.